Although subcutaneous injection continues as the standard treatment approach, oral GLP-1RA therapy, together with new delivery technologies such as transdermal patches, demonstrate the arrival of more convenient administration options for this class of medication [67]
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
Furthermore, if there are any ongoing infections or immune-related issues contributing to the overall health decline, immunity-boosting IV therapy might be an effective solution to explore before starting peptide therapy
The Wegovy pill appears to produce weight loss in the same general range as injectable Wegovy
PubMed Central, doi:10.1016/j.reprotox.2015.09.006